Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01399-09
Full Text
Open PDFAbstract
Available in full text
Date
January 25, 2010
Authors
Publisher
American Society for Microbiology